Valproic acid (VPA) attenuated cardiac hypertrophy and fibrosis through acetylation of the mineralocorticoid receptor in spontaneously hypertensive rats [156] and avoided right ventricular hypertrophy. This evidence concerns the gene NR3C2 and cardiac hypertrophy.